SCHEMBL25052856

SCHEMBL25052856

CCCCCC(=O)NC(C)C(=O)NC(C)C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.49
MEN1 O00255 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 1/20 0.49
BIRC2 Q13490 1/20 0.45
DNM1 Q05193 1/20 0.41
ASAH2 Q9NR71 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SLC6A5 Q9Y345 1/20 0.41
PLA2G10 O15496 2/20 0.39
PRSS1 P07477 1/20 0.39
CTSG P08311 1/20 0.39
CTRB1 P17538 1/20 0.39
CMA1 P23946 1/20 0.39
NOD1 Q9Y239 1/20 0.38
PLA2G2C Q5R387 1/20 0.38
CAPN1 P07384 1/20 0.38
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38
CPT1B Q92523 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31529071 0.93 FAAH (0.57) FAAHMEN1MAPK1KMT2ADNM1
SCHEMBL7151887 0.93 FAAH (0.57) FAAHMEN1MAPK1KMT2ADNM1
SCHEMBL7098518 0.93 FAAH (0.57) FAAHMEN1MAPK1KMT2ADNM1
SCHEMBL7151886 0.93 FAAH (0.57) FAAHMEN1MAPK1KMT2ADNM1
SCHEMBL31529223 0.93 FAAH (0.57) FAAHMEN1MAPK1KMT2ADNM1
SCHEMBL31421853 0.90 FAAH (0.47) FAAHMEN1MAPK1KMT2ABIRC2
SCHEMBL26231755 0.89 PLA2G10 (0.38) FAAHMEN1MAPK1KMT2ABIRC2
SCHEMBL25052849 0.89 PLA2G10 (0.38) FAAHMEN1MAPK1KMT2ABIRC2
SCHEMBL17616958 0.87 RECQL (0.39) KMT2ABIRC2CAPN1
SCHEMBL17570956 0.87 RECQL (0.39) KMT2ABIRC2CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018960-A1 IMPROVED METHODS FOR PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES IMMUNOGEN, INC. (US) 2023-02-16 WO disclosed